Use of mycophenolate mofetil in resistant membranous nephropathy

Appel, 2000, Glomerulonephritis, 586 Korbet, 1996, The racial prevalence of glomerular lesions in nephrotic adults, Am J Kidney Dis, 27, 647, 10.1016/S0272-6386(96)90098-0 Haas, 1995, Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: A 20-year renal biopsy study, Am J Kidney Dis, 26, 740, 10.1016/0272-6386(95)90437-9 Hogan, 1995, A review of therapeutic studies of idiopathic membranous glomerulopathy, Am J Kidney Dis, 25, 862, 10.1016/0272-6386(95)90568-5 Imperiale, 1995, Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials, J Am Soc Nephrol, 5, 1553, 10.1681/ASN.V581553 Hebert, 1995, Therapy of membranous nephropathy: What to do after the after (meta) analyses, J Am Soc Nephrol, 5, 1543, 10.1681/ASN.V581543 Lewis, 1993, Idiopathic membranous nephropathy—To treat or not to treat?, N Engl J Med, 329, 127, 10.1056/NEJM199307083290211 1979, A controlled study of short-term prednisone treatment in adults with membranous nephropathy, N Engl J Med, 301, 1301, 10.1056/NEJM197912133012401 Cattran, 1989, A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy, N Engl J Med, 320, 210, 10.1056/NEJM198901263200403 Cameron, 1990, The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party, Q J Med, 74, 133, 10.1093/oxfordjournals.qjmed.a068422 Bolton, 1977, Therapy of the idiopathic nephrotic syndrome with alternate-day steroids, Am J Med, 62, 60, 10.1016/0002-9343(77)90350-3 Ponticelli, 1992, Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy, N Engl J Med, 327, 599, 10.1056/NEJM199208273270904 Ponticelli, 1998, A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy, J Am Soc Nephrol, 9, 444, 10.1681/ASN.V93444 Jindal, 1992, Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function, Am J Kidney Dis, 19, 61, 10.1016/S0272-6386(12)70204-4 Bruns, 1991, Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone, Ann Intern Med, 114, 725, 10.7326/0003-4819-114-9-725 Murphy, 1992, Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis, Clin Nephrol, 37, 229 Warwick, 1994, Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure, Q J Med, 87, 223 Falk, 1992, Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone, Ann Intern Med, 116, 438, 10.7326/0003-4819-116-6-438 Reichert, 1994, Preserving renal function in patients with membranous nephropathy: Daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide, Ann Intern Med, 121, 328, 10.7326/0003-4819-121-5-199409010-00003 Ponticelli, 1995, A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy, Kidney Int, 48, 1600, 10.1038/ki.1995.453 Schieppati, 1993, Prognosis of untreated patients with idiopathic membranous nephropathy, N Engl J Med, 329, 85, 10.1056/NEJM199307083290203 Wakai, 1992, Focal glomerulosclerosis in idiopathic membranous glomerulonephritis, Kidney Int, 41, 428, 10.1038/ki.1992.59 Pei, 1992, Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis, Kidney Int, 42, 960, 10.1038/ki.1992.374 Cattran, 1997, Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications, Kidney Int, 51, 901, 10.1038/ki.1997.127 Marx, 1997, Prognosis of idiopathic membranous nephropathy: A methodologic meta-analysis, Kidney Int, 51, 873, 10.1038/ki.1997.123 Reichert, 1998, Prognostic factors in idiopathic membranous nephropathy, Am J Kidney Dis, 31, 1, 10.1053/ajkd.1998.v31.pm9428445 The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group, 1996, A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation, Transplantation, 61, 1029, 10.1097/00007890-199604150-00008 European Mycophenolate Mofetil Cooperative Study Group, 1995, Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection, Lancet, 345, 1321, 10.1016/S0140-6736(95)92534-1 Glicklich, 1998, Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide, Am J Kidney Dis, 32, 318, 10.1053/ajkd.1998.v32.pm9708620 Briggs, 1998, Successful mycophenolate mofetil treatment of glomerular disease, Am J Kidney Dis, 31, 213, 10.1053/ajkd.1998.v31.pm9469489 Nowack, 1997, Mycophenolate mofetil is effective for maintenance of systemic vasculitis, J Am Soc Nephrol, 8, 95A Dooley, 1999, Mycophenolate mofetil therapy in lupus nephritis: Clinical observations, J Am Soc Nephrol, 10, 833, 10.1681/ASN.V104833 Hebert, 1997, Mycophenolate mofetil therapy of systemic lupus erythematosus and ANCA vasculitis, J Am Soc Nephrol, 8, 87A Briggs, 1998, Follow-up on mycophenolate treatment of glomerular disease, Am J Kidney Dis, 31, 898, 10.1053/ajkd.1998.v31.pm9469489 Cattran, 1995, A controlled trial of cyclosporine in patients with progressive membranous nephropathy, Kidney Int, 47, 1130, 10.1038/ki.1995.161 Cattran, 1999, Randomized controlled trial of cyclosporine vs placebo in steroid resistant, nephrotic patients, with membranous nephropathy, J Am Soc Nephrol, 9, 85A Boumpas, 1999, A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy, Clin Nephrol, 52, 67 1999, A randomized, controlled trial of cyclosporine in steroid-resistant focal segmental glomerulosclerosis, Kidney Int, 56, 2220, 10.1046/j.1523-1755.1999.00778.x